251 related articles for article (PubMed ID: 16801165)
1. Macrophage activation syndrome in juvenile idiopathic arthritis.
Cortis E; Insalaco A
Acta Paediatr Suppl; 2006 Jul; 95(452):38-41. PubMed ID: 16801165
[TBL] [Abstract][Full Text] [Related]
2. The clinical spectrum and treatment options of macrophage activation syndrome in the pediatric age.
Stabile A; Bertoni B; Ansuini V; La Torraca I; Sallì A; Rigante D
Eur Rev Med Pharmacol Sci; 2006; 10(2):53-9. PubMed ID: 16705949
[TBL] [Abstract][Full Text] [Related]
3. Macrophage activation syndrome following initiation of etanercept in a child with systemic onset juvenile rheumatoid arthritis.
Ramanan AV; Schneider R
J Rheumatol; 2003 Feb; 30(2):401-3. PubMed ID: 12563702
[TBL] [Abstract][Full Text] [Related]
4. A case report of successful treatment with plasma exchange for hemophagocytic syndrome associated with severe systemic juvenile idiopathic arthritis in an infant girl.
Nakakura H; Ashida A; Matsumura H; Murata T; Nagatoya K; Shibahara N; Inoue T; Tamai H
Ther Apher Dial; 2009 Feb; 13(1):71-6. PubMed ID: 19379173
[TBL] [Abstract][Full Text] [Related]
5. Acute liver failure in young children with systemic-onset juvenile idiopathic arthritis without macrophage activation syndrome: report of two cases.
Hiejima E; Komatsu H; Takeda Y; Sogo T; Inui A; Okafuji I; Nishikomori R; Nakahata T; Fujisawa T
J Paediatr Child Health; 2012 Mar; 48(3):E122-5. PubMed ID: 22050445
[TBL] [Abstract][Full Text] [Related]
6. Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis.
Hazen MM; Woodward AL; Hofmann I; Degar BA; Grom A; Filipovich AH; Binstadt BA
Arthritis Rheum; 2008 Feb; 58(2):567-70. PubMed ID: 18240215
[TBL] [Abstract][Full Text] [Related]
7. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?
Behrens EM
Autoimmun Rev; 2008 Feb; 7(4):305-8. PubMed ID: 18295734
[TBL] [Abstract][Full Text] [Related]
8. Recognition and management of macrophage activation syndrome in juvenile arthritis.
Kelly A; Ramanan AV
Curr Opin Rheumatol; 2007 Sep; 19(5):477-81. PubMed ID: 17762614
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate as a possible trigger of macrophage activation syndrome in systemic juvenile idiopathic arthritis.
Ravelli A; Caria MC; Buratti S; Malattia C; Temporini F; Martini A
J Rheumatol; 2001 Apr; 28(4):865-7. PubMed ID: 11327264
[TBL] [Abstract][Full Text] [Related]
10. Etanercept for therapy-resistant macrophage activation syndrome.
Makay B; Yilmaz S; Türkyilmaz Z; Unal N; Oren H; Unsal E
Pediatr Blood Cancer; 2008 Feb; 50(2):419-21. PubMed ID: 16900487
[TBL] [Abstract][Full Text] [Related]
11. Differentiating macrophage activation syndrome in systemic juvenile idiopathic arthritis from other forms of hemophagocytic lymphohistiocytosis.
Lehmberg K; Pink I; Eulenburg C; Beutel K; Maul-Pavicic A; Janka G
J Pediatr; 2013 Jun; 162(6):1245-51. PubMed ID: 23333131
[TBL] [Abstract][Full Text] [Related]
12. Distinct cytokine profiles of systemic-onset juvenile idiopathic arthritis-associated macrophage activation syndrome with particular emphasis on the role of interleukin-18 in its pathogenesis.
Shimizu M; Yokoyama T; Yamada K; Kaneda H; Wada H; Wada T; Toma T; Ohta K; Kasahara Y; Yachie A
Rheumatology (Oxford); 2010 Sep; 49(9):1645-53. PubMed ID: 20472718
[TBL] [Abstract][Full Text] [Related]
13. Macrophage activation syndrome in juvenile systemic lupus erythematosus: an under-recognized complication?
Pringe A; Trail L; Ruperto N; Buoncompagni A; Loy A; Breda L; Martini A; Ravelli A
Lupus; 2007; 16(8):587-92. PubMed ID: 17711893
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis A-associated macrophage activation syndrome in children with systemic juvenile idiopathic arthritis: report of 2 cases.
Russo RA; Rosenzweig SD; Katsicas MM
J Rheumatol; 2008 Jan; 35(1):166-8. PubMed ID: 18050365
[TBL] [Abstract][Full Text] [Related]
15. The incidence of macrophage activation syndrome in children with rheumatic disorders.
Moradinejad MH; Ziaee V
Minerva Pediatr; 2011 Dec; 63(6):459-66. PubMed ID: 22075800
[TBL] [Abstract][Full Text] [Related]
16. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis.
Bleesing J; Prada A; Siegel DM; Villanueva J; Olson J; Ilowite NT; Brunner HI; Griffin T; Graham TB; Sherry DD; Passo MH; Ramanan AV; Filipovich A; Grom AA
Arthritis Rheum; 2007 Mar; 56(3):965-71. PubMed ID: 17328073
[TBL] [Abstract][Full Text] [Related]
17. Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases.
Tristano AG
Med Sci Monit; 2008 Mar; 14(3):RA27-36. PubMed ID: 18301366
[TBL] [Abstract][Full Text] [Related]
18. [A case of macrophage activation syndrome developed with systemic juvenile rheumatoid arthritis].
Imagawa T; Katakura S; Mori M; Aihara Y; Mitsuda T; Yokota S
Ryumachi; 1997 Jun; 37(3):487-92. PubMed ID: 9256033
[TBL] [Abstract][Full Text] [Related]
19. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis.
Behrens EM; Beukelman T; Paessler M; Cron RQ
J Rheumatol; 2007 May; 34(5):1133-8. PubMed ID: 17343315
[TBL] [Abstract][Full Text] [Related]
20. Experience with hemophagocytic lymphohistiocytosis/macrophage activation syndrome at a single institution.
Gupta AA; Tyrrell P; Valani R; Benseler S; Abdelhaleem M; Weitzman S
J Pediatr Hematol Oncol; 2009 Feb; 31(2):81-4. PubMed ID: 19194188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
